Other languages GlaxoSmithKline plc LIQUIDNET SYSTEMS

Equities

Delayed LIQUIDNET SYSTEMS Other stock markets			5-day change	1st Jan Change
- ^EUR	-.--%		-0.40%	-.--%

01/06	Delaware judge lets more than 70,000 Zantac lawsuits go forward	RE
01/06	GSK Regarding Ruling By Delaware State Court On Zantac Litigation Will Immediately Seek Appeal	RE

Delaware judge lets more than 70,000 Zantac lawsuits go forward	02/06
GSK Regarding Ruling By Delaware State Court On Zantac Litigation Will Immediately Seek Appeal	01/06
US FDA approves Moderna's RSV vaccine, its second marketed product	31/05
Goldman Sachs Starts GSK With Neutral Rating, $47 Price Target	30/05
Goldman Sachs Initiates GlaxoSmithKline with Neutral Rating	30/05
Jefferies and UBS cut Anglo American	30/05
Dr Martens cuts payout as profit plummets	30/05
GSK : Upgraded to Neutral by Goldman Sachs	30/05
US nears deal to fund Moderna's bird flu vaccine trial, FT reports	30/05
European Equities Traded in the US as American Depositary Receipts Trend Sharply Lower in Wednesday Trading	29/05
New data at ASCO showcases the transformational potential of GSK's oncology portfolio \| GSK	29/05
CureVac, GSK Begin Dosing in Phase 2 Study for Seasonal Influenza Vaccine Candidate	28/05
US, European nations consider vaccinating workers exposed to bird flu	27/05
British Stocks Extend Losing Streak Amid Retail Sales Slump	24/05
Statement: Zantac (ranitidine) litigation - Valadez and Williams cases - Form 6-K	24/05
Rate outlook weighs on equities	24/05
GSK : obtient gain de cause dans une affaire liée au Zantac	24/05
New data at ASCO showcases the transformational potential of GSK's oncology portfolio \| GSK	24/05
GSK : va présenter ses avancées en oncologie lors de l'ASCO	24/05
Statement: Zantac (ranitidine) litigation - Valadez and Williams cases \| GSK	24/05

No results for this search

GSK plc : Back on track

May 03, 2024 at 02:47 pm IST

GSK PLC : Encouraging start to 2024; guidance raised